Connect with us

Business

Rhythm (ASX:RHY) share price surges 10% on ColoSTAT results

Published

on

ADVERTISEMENT

The Rhythm Biosciences Ltd (ASX: RHY) share price is a strong mover today following the release of its ColoSTAT results.

Rhythm’s ColoSTAT is an experimental test-kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.

At the time of writing, the…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

3 excellent ASX growth shares rated as buys
2 ASX dividend shares with attractive fully franked yields